Stay updated with breaking news from ஹால் பரோன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK - GlaxoSmithKline plc (via Public) / GSK and Alector announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases (Form 6-K) publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: GSK and Alector collaboration in immuno-neurology investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
GSK Enters into Global Collaboration with Alector to Develop Antibodies for Neurodegenerative Diseases globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines GlaxoSmithKline announces $700 million collaboration with Alector investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
GSK, Alector to develop Parkinson's, Alzheimer's drugs in $2.2 bln deal reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.